Gene expression alterations in the postmortem hippocampus from older patients with bipolar disorder-A hypothesis generating study

Imagem de Miniatura
Arquivos
art_NASCIMENTO_Gene_expression_alterations_in_the_postmortem_hippocampus_from_2023.PDF (494.49 KB)
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
PERGAMON-ELSEVIER SCIENCE LTD
Autores
KIM, Helena Kyunghee
CRISTINA, De Oliveira Katia
BARBOSA, Andre
Citação
JOURNAL OF PSYCHIATRIC RESEARCH, v.164, p.329-334, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Bipolar disorder (BD) presents with a progressive course in a subset of patients. However, our knowledge of molecular changes in older BD is limited. In this study, we examined gene expression changes in the hippocampus of BD from the Biobank of Aging Studies to identify genes of interest that warrant further exploration. RNA was extracted from the hippocampus from 11 subjects with BD and 11 age and sex-matched controls. Gene expression data was generated using the SurePrint G3 Human Gene Expression v3 microarray. Rank feature selection was performed to identify a subset of features that can optimally differentiate BD and controls. Genes ranked in the top 0.1% with log2 fold change >1.2 were identified as genes of interest. Average age of the subjects was 64 years old; duration of disease was 21 years and 82% were female. Twenty-five genes were identified, of which all but one was downregulated in BD. Of these, CNTNAP4, MAP4, SLC4A1, COBL, and NEURL4 had been associated with BD and other psychiatric conditions in previous studies. We believe our findings have identified promising targets to inform future studies aiming to understand the pathophysiology of BD in later life.
Palavras-chave
Bipolar disorder, Transcriptome, Gene expression, Hippocampus, Postmortem brain
URI
https://observatorio.fm.usp.br/handle/OPI/54751
Referências
  1. Al Shweiki MHDR, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0825-7
  2. Alhenawi E, 2022, COMPUT BIOL MED, V140, DOI 10.1016/j.compbiomed.2021.105051
  3. Berk M, 2011, NEUROSCI BIOBEHAV R, V35, P804, DOI 10.1016/j.neubiorev.2010.10.001
  4. Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96
  5. Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
  6. Brietzke E, 2010, BIPOLAR DISORD, V12, P453, DOI 10.1111/j.1399-5618.2010.00822.x
  7. Cerimele JM, 2017, J CLIN PSYCHIAT, V78, pE506, DOI 10.4088/JCP.16r10897
  8. Che Y, 2010, J PSYCHIATR NEUROSCI, V35, P296, DOI 10.1503/jpn.090083
  9. Chen C, 2014, BIPOLAR DISORD, V16, P790, DOI 10.1111/bdi.12255
  10. Chepenik LG, 2012, BIOL PSYCHOL, V90, P18, DOI 10.1016/j.biopsycho.2012.01.008
  11. Choi J, 2021, J PSYCHIATR RES, V142, P328, DOI 10.1016/j.jpsychires.2021.08.011
  12. Cohen-Mansfield J, 2013, INT J AGING HUM DEV, V77, P37, DOI 10.2190/AG.77.1.c
  13. Conejero I, 2018, CLIN INTERV AGING, V13, P691, DOI 10.2147/CIA.S130670
  14. Coon H, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.100
  15. de Oliveira KC, 2012, CELL TISSUE BANK, V13, P315, DOI 10.1007/s10561-011-9258-0
  16. Du XH, 2022, ENVIRON INT, V163, DOI 10.1016/j.envint.2022.107242
  17. Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0
  18. Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde
  19. Gigante AD, 2011, INT J NEUROPSYCHOPH, V14, P1075, DOI 10.1017/S146114571000146X
  20. Grewal S, 2023, AUST NZ J PSYCHIAT, V57, P328, DOI 10.1177/00048674221091731
  21. Harrison PJ, 2020, MOL PSYCHIATR, V25, P1787, DOI 10.1038/s41380-018-0213-3
  22. Karayannis T, 2014, NATURE, V511, P236, DOI 10.1038/nature13248
  23. Kessing LV, 2004, ACTA PSYCHIAT SCAND, V109, P339, DOI 10.1046/j.1600-0447.2003.00266.x
  24. Kim HK, 2019, J PSYCHIATR RES, V110, P38, DOI 10.1016/j.jpsychires.2018.12.007
  25. Kim HK, 2018, J PSYCHIATR RES, V99, P39, DOI 10.1016/j.jpsychires.2018.01.011
  26. Kim HK, 2016, J PSYCHIATR RES, V72, P43, DOI 10.1016/j.jpsychires.2015.10.015
  27. Kim HK, 2014, J PSYCHIATR NEUROSCI, V39, P276, DOI 10.1503/jpn.130155
  28. Kupka R, 2021, BIPOLAR DISORD, V23, P659, DOI 10.1111/bdi.13105
  29. Lanz TA, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0492-8
  30. Leirer DJ, 2019, SCHIZOPHR RES, V209, P88, DOI 10.1016/j.schres.2019.05.011
  31. Li ZF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202167
  32. Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
  33. Nascimento C, 2020, BRAIN BEHAV IMMUN, V90, P286, DOI 10.1016/j.bbi.2020.08.034
  34. Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x
  35. Park SW, 2022, TRANSL PSYCHIAT, V12, DOI 10.1038/s41398-022-01944-8
  36. Phillips ML, 2014, AM J PSYCHIAT, V171, P829, DOI 10.1176/appi.ajp.2014.13081008
  37. Ren R., 2017, ONCOTARGET
  38. Sadeghi I, 2022, COMPUT STRUCT BIOTEC, V20, P4549, DOI 10.1016/j.csbj.2022.08.037
  39. Safran M., 2021, PRACTICAL GUIDE LIFE, P27, DOI 10.1007/978-981-16-5812-9_2
  40. Sajatovic M, 2019, BIPOLAR DISORD, V21, P642, DOI 10.1111/bdi.12795
  41. Sajatovic M, 2013, NEUROPSYCHIATRY-LOND, V3, P621, DOI 10.2217/npy.13.78
  42. Scarr E, 2019, AUST NZ J PSYCHIAT, V53, P1189, DOI 10.1177/0004867419857808
  43. Suemoto CK, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002267
  44. Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111
  45. Toma C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3382
  46. Valnegri P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01333-6
  47. Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6
  48. Xie PX, 2013, BIOL PSYCHIAT, V74, P656, DOI 10.1016/j.biopsych.2013.04.013

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Carregar mais